EP2288350A4 - Méthode de traitement faisant appel à un stéréoisomère dynamisé de glutamate - Google Patents

Méthode de traitement faisant appel à un stéréoisomère dynamisé de glutamate

Info

Publication number: EP2288350A4
Authority: EP; European Patent Office
Prior art keywords: glutamate; treatment; potentised; stereoisomer; potentised stereoisomer
Prior art date: 2008-01-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP08841975A

Other languages

German (de)

English (en)

Other versions

EP2288350A1 (fr

Inventor

Reinhard Michael Kuzeff

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sempach Pty Ltd

Original Assignee

Sempach Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-01-22

Filing date

2008-11-03

Publication date

2012-01-04

2008-01-22 Priority claimed from AU2008900291A external-priority patent/AU2008900291A0/en

2008-11-03 Application filed by Sempach Pty Ltd filed Critical Sempach Pty Ltd

2011-03-02 Publication of EP2288350A1 publication Critical patent/EP2288350A1/fr

2012-01-04 Publication of EP2288350A4 publication Critical patent/EP2288350A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Alternative & Traditional Medicine (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP08841975A 2008-01-22 2008-11-03 Méthode de traitement faisant appel à un stéréoisomère dynamisé de glutamate Withdrawn EP2288350A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AU2008900291A AU2008900291A0 (en)		2008-01-22	Method of treatment
AU2008904478A AU2008904478A0 (en)		2008-08-29	Method of treatment
PCT/AU2008/001611 WO2009052591A1 (fr)	2008-01-22	2008-11-03	Méthode de traitement faisant appel à un stéréoisomère dynamisé de glutamate

Publications (2)

Publication Number	Publication Date
EP2288350A1 EP2288350A1 (fr)	2011-03-02
EP2288350A4 true EP2288350A4 (fr)	2012-01-04

Family

ID=40578990

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP08841975A Withdrawn EP2288350A4 (fr)	2008-01-22	2008-11-03	Méthode de traitement faisant appel à un stéréoisomère dynamisé de glutamate

Country Status (3)

Country	Link
EP (1)	EP2288350A4 (fr)
CA (1)	CA2711839A1 (fr)
WO (1)	WO2009052591A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0884042A1 (fr) *	1996-02-12	1998-12-16	Oleg Iliich Epshtein	Medicament et procede d'action medicamenteuse sur l'organisme
WO2003072105A1 (fr) *	2002-02-28	2003-09-04	Sempach Pty Ltd	Neutralisation de l'effet de produits chimiques par leurs stereoisomeres ultradilues

2008
- 2008-11-03 EP EP08841975A patent/EP2288350A4/fr not_active Withdrawn
- 2008-11-03 CA CA2711839A patent/CA2711839A1/fr not_active Abandoned
- 2008-11-03 WO PCT/AU2008/001611 patent/WO2009052591A1/fr not_active Ceased

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0884042A1 (fr) *	1996-02-12	1998-12-16	Oleg Iliich Epshtein	Medicament et procede d'action medicamenteuse sur l'organisme
WO2003072105A1 (fr) *	2002-02-28	2003-09-04	Sempach Pty Ltd	Neutralisation de l'effet de produits chimiques par leurs stereoisomeres ultradilues

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CORTESE BERNADETTE M ET AL: "The role of glutamate in anxiety and related disorders.", CNS SPECTRUMS OCT 2005 LNKD- PUBMED:16400245, vol. 10, no. 10, October 2005 (2005-10-01), pages 820 - 830, XP002664558, ISSN: 1092-8529 *
JONAS W ET AL: "NEUROPROTECTION FROM GLUTAMATE TOXICITY WITH ULTRA-LOW DOSE GLUTAMATE", NEUROREPORT, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 12, no. 2, 12 February 2001 (2001-02-12), pages 335 - 339, XP008076722, ISSN: 0959-4965, DOI: 10.1097/00001756-200102120-00031 *
See also references of WO2009052591A1 *

Also Published As

Publication number	Publication date
WO2009052591A1 (fr)	2009-04-30
EP2288350A1 (fr)	2011-03-02
CA2711839A1 (fr)	2009-04-30

Publication	Publication Date	Title
IL208354A0 (en)	2010-12-30	Methods of treatment
IL207752A0 (en)	2010-12-30	Methods of treating inflammation
IL212348A0 (en)	2011-06-30	Treatment method
EP2331564A4 (fr)	2013-02-20	Procédés de traitement de l'inflammation
IL211061A0 (en)	2011-04-28	Methods of treating thalassemia
EP2313103A4 (fr)	2012-08-08	Procédé de traitement d'une blépharite
EP2350641A4 (fr)	2012-10-31	Procédé de traitement
NO2016023I1 (no)	2016-12-14	Glycerol fenylbutyrat
GEP20135843B (en)	2013-06-10	Method of scanning
HRP20181877T1 (hr)	2019-01-11	Postupci za liječenje lijekovima koji uklanjaju amonijak
VN25747A1 (en)	2011-04-25	Method of water treatment
PL2318573T3 (pl)	2017-09-29	Sposób obróbki przeciwkorozyjnej
EP2164494A4 (fr)	2010-06-02	Procédés de traitement
EP2303284A4 (fr)	2013-04-24	Procédés de traitement d'un trouble bipolaire
GB2459738B (en)	2013-03-06	Method of purification
ZA201005206B (en)	2011-09-28	Method of treating hair
ZA201007680B (en)	2011-09-28	Method of treating metalliferrous materials
IL216456A0 (en)	2012-01-31	Method of treating frailty
EP2424539A4 (fr)	2012-09-19	Procédé de traitement d'une dépression
EP2288350A4 (fr)	2012-01-04	Méthode de traitement faisant appel à un stéréoisomère dynamisé de glutamate
EP2203432A4 (fr)	2011-04-27	Procédé de traitement
GB0823435D0 (en)	2009-01-28	Method of treatment
GB0800556D0 (en)	2008-02-20	Method of treatment and treatment therefor
AU2008904356A0 (en)	2008-09-11	Method of Treatment
AU2008900291A0 (en)	2008-02-07	Method of treatment

Legal Events

Date	Code	Title	Description
2011-01-28	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2011-03-02	17P	Request for examination filed	Effective date: 20101201
2011-03-02	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2011-03-02	AX	Request for extension of the european patent	Extension state: AL BA MK RS
2011-04-27	DAX	Request for extension of the european patent (deleted)
2012-01-04	A4	Supplementary search report drawn up and despatched	Effective date: 20111206
2012-01-04	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 41/00 20060101ALI20111129BHEP Ipc: A61P 25/30 20060101ALI20111129BHEP Ipc: A61P 25/22 20060101ALI20111129BHEP Ipc: A61P 25/24 20060101ALI20111129BHEP Ipc: A61K 31/198 20060101AFI20111129BHEP
2014-11-07	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2014-12-10	18D	Application deemed to be withdrawn	Effective date: 20140501